Delivery of neuroactive peptide drugs to the brain via intranasal delivery

Cros, Cecile D.; Toth, Istvan; Blanchfield, Joanne T.

dc.contributor.author	Cros, Cecile D.
dc.contributor.author	Toth, Istvan
dc.contributor.author	Blanchfield, Joanne T.
dc.date.accessioned	2006-11-21T22:17:58Z
dc.date.available	2006-11-21T22:17:58Z
dc.date.issued	2006-10-27
dc.identifier.uri	http://hdl.handle.net/1808/1182
dc.format.extent	92113 bytes
dc.format.mimetype	application/pdf
dc.language	en
dc.relation.ispartofseries	PS;46
dc.title	Delivery of neuroactive peptide drugs to the brain via intranasal delivery
dc.type	Presentation
kusw.oastatus	na
kusw.oapolicy	This item does not meet KU Open Access policy criteria.
dc.rights.accessrights	openAccess

Files in this item

Name:: PS46 Cros.pdf
Size:: 89.95Kb
Format:: PDF

View/Open

This item appears in the following Collection(s)

The University of Kansas prohibits discrimination on the basis of race, color, ethnicity, religion, sex, national origin, age, ancestry, disability, status as a veteran, sexual orientation, marital status, parental status, gender identity, gender expression and genetic information in the University’s programs and activities. The following person has been designated to handle inquiries regarding the non-discrimination policies: Director of the Office of Institutional Opportunity and Access, IOA@ku.edu, 1246 W. Campus Road, Room 153A, Lawrence, KS, 66045, (785)864-6414, 711 TTY.